Carbamazepine and its metabolites in wastewater: Analytical pitfalls and occurrence in Germany and Portugal

被引：196

作者：

Bahlmann, Arnold ^{[1
]}

Brack, Werner ^{[1
]}

Schneider, Rudolf J. ^{[2
]}

Krauss, Martin ^{[1
]}

机构：

[1] UFZ Helmholtz Ctr Environm Res, Dept Effect Directed Anal, D-04318 Leipzig, Germany

[2] BAM Fed Inst Mat Res & Testing, D-12489 Berlin, Germany

来源：

WATER RESEARCH | 2014年 / 57卷

关键词：

Carbamazepine; Hydroxycarbamazepine; Metabolite; Wastewater; Pharmaceutical; LC-MS/MS; SEWAGE-TREATMENT PLANTS; LIQUID-CHROMATOGRAPHY; PHARMACEUTICALS; SURFACE; 10,11-EPOXIDE; ESTROGENS; BEHAVIOR; URINE; FATE;

D O I：

10.1016/j.watres.2014.03.022

中图分类号：

X [环境科学、安全科学];

学科分类号：

08 ; 0830 ;

摘要：

The occurrence of carbamazepine (CBZ) and its metabolites in German and Portuguese wastewater was investigated. A total of 46 samples from influent and effluent wastewater were analyzed by liquid-chromatography (LC) tandem mass spectrometry. The five metabolites 10,11-dihydro-10,11-dihydroxy-CBZ (DiOH-CBZ), 10,11-dihydro-10-hydroxy-CBZ (10-OH-CBZ), 10,11-epoxy-10,11-dihydro-CBZ, 2-hydroxy-CBZ and 3-hydroxy-CBZ were very persistent with little to no removal during wastewater treatment. The highest concentrations were found for CBZ, DiOH-CBZ, and 10-OH-CBZ, with up to 5.0, 4.8 and 1.1 mu g/L, respectively. Furthermore, the related pharmaceutical oxcarbazepine and the metabolites 9-hydroxymethy1-10-carbamoylacridan, 1-hydroxy-CBZ (1-OH-CBZ) and 4-hydroxy-CBZ (4OH-CBZ) were detected. Explicit care was taken to achieve a good chromatographic separation of the numerous isomers that were difficult to distinguish by mass spectrometry alone. A phenylether stationary phase provided the best separation. In combination with high resolution mass spectrometry and hydrogen-deuterium exchange, this LC column enabled us to identify 1-OH-CBZ and 4-OH-CBZ in wastewater for the first time. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：104 / 114

页数：11

共 40 条

[1]

AXELROD J, 1958, J BIOL CHEM, V232, P835

[2] Immunoassays as high-throughput tools: Monitoring spatial and temporal variations of carbamazepine, caffeine and cetirizine in surface and wastewaters [J].

Bahlmann, Arnold ;

Carvalho, Jose Joao ;

Weller, Michael G. ;

Panne, Ulrich ;

Schneider, Rudolf J. .

CHEMOSPHERE, 2012, 89 (11) :1278-1286

[3] Monitoring carbamazepine in surface and wastewaters by an immunoassay based on a monoclonal antibody [J].

Bahlmann, Arnold ;

Weller, Michael G. ;

Panne, Ulrich ;

Schneider, Rudolf J. .

ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 395 (06) :1809-1820

[4] NEW N-GLUCURONIDE METABOLITE OF CARBAMAZEPINE [J].

BAUER, JE ;

GERBER, N ;

LYNN, RK ;

SMITH, RG ;

THOMPSON, RM .

EXPERIENTIA, 1976, 32 (08) :1032-1033

[5] The mechanism of the carbamazepine-valproate interaction in humans [J].

Bernus, I ;

Dickinson, RG ;

Hooper, WD ;

Eadie, MJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (01) :21-27

[6] Application of an ELISA to the quantification of carbamazepine in ground, surface and wastewaters and validation with LC-MS/MS [J].

Calisto, Vania ;

Bahlmann, Arnold ;

Schneider, Rudolf J. ;

Esteves, Valdemar I. .

CHEMOSPHERE, 2011, 84 (11) :1708-1715

[7] Trace Analysis of Polar Pharmaceuticals in Wastewater by LC-MS-MS: Comparison of Membrane Bioreactor and Activated Sludge Systems [J].

Celiz, Mary Dawn ;

Perez, Sandra ;

Barcelo, Damia ;

Aga, Diana S. .

JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2009, 47 (01) :19-25

[8] Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration [J].

Clara, M ;

Strenn, B ;

Kreuzinger, N .

WATER RESEARCH, 2004, 38 (04) :947-954

[9] Product ion mobility as a promising tool for assignment of positional isomers of drug metabolites [J].

Cuyckens, Filip ;

Wassvik, Carola ;

Mortishire-Smith, Russell J. ;

Tresadern, Gary ;

Campuzano, Iain ;

Claereboudt, Jan .

RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2011, 25 (23) :3497-3503

[10]

Faigle J.W., 1975, Clinical Pharmacology of Anti-Epileptic Drugs, P159, DOI DOI 10.1007/978-3-642-85921-2_15

← 1 2 3 4 →